• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丘斯 2 评分在库欣综合征患者主要不良心血管事件预测中的应用。

CHADS 2 Scores in the Prediction of Major Adverse Cardiovascular Events in Patients with Cushing's Syndrome.

机构信息

Department of Nuclear Medicine, Dalin Tzu Chi General Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan ; School of Medicine, Tzu Chi University, Hualian, Taiwan.

Department of Pharmacy, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan.

出版信息

Int J Endocrinol. 2014;2014:138653. doi: 10.1155/2014/138653. Epub 2014 Jul 1.

DOI:10.1155/2014/138653
PMID:25101124
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4102001/
Abstract

Vascular events are one of the major causes of death in case of Cushing's syndrome (CS). However, due to the relative low frequency of CS, it is hard to perform a risk assessment for these events. As represented congestive heart failure (C), hypertension (H), age (A), diabetes (D), and stroke (S), the CHADS2 score is now accepted to classify the risk of major adverse cardiovascular events (MACEs) in patients with atrial fibrillation. In this study, participants were enrolled from the National Health Research Institute Database (NHIRD) of Taiwan, and we reviewed 551 patients with their sequential clinically diagnosed CS data between 2002 and 2009 in relation to MACEs risk using CHADS2 score. Good correlation could be identified between the CS and CHADS2 score (AUC = 0.795). Our results show that patients with CS show significantly higher risk of vascular events and the CHADS2 score could be applied for MACEs evaluation. Adequate lifestyle modifications and aggressive cardiovascular risks treatment are suggested for CS patients with higher CHADS2 score.

摘要

血管事件是库欣综合征(CS)患者死亡的主要原因之一。然而,由于 CS 的相对低频率,很难对这些事件进行风险评估。CHADS2 评分代表充血性心力衰竭(C)、高血压(H)、年龄(A)、糖尿病(D)和中风(S),现在被用于分类心房颤动患者发生主要不良心血管事件(MACEs)的风险。在这项研究中,参与者是从台湾国家健康研究研究所数据库(NHIRD)中招募的,我们回顾了 2002 年至 2009 年期间 551 例连续临床诊断为 CS 的患者的数据,使用 CHADS2 评分评估其发生 MACEs 的风险。CS 与 CHADS2 评分之间存在良好的相关性(AUC=0.795)。我们的结果表明,CS 患者发生血管事件的风险显著增加,CHADS2 评分可用于评估 MACEs。建议 CHADS2 评分较高的 CS 患者进行适当的生活方式改变和积极的心血管风险治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b7f/4102001/a97aca7426f1/IJE2014-138653.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b7f/4102001/4bfc749269ad/IJE2014-138653.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b7f/4102001/a97aca7426f1/IJE2014-138653.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b7f/4102001/4bfc749269ad/IJE2014-138653.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2b7f/4102001/a97aca7426f1/IJE2014-138653.002.jpg

相似文献

1
CHADS 2 Scores in the Prediction of Major Adverse Cardiovascular Events in Patients with Cushing's Syndrome.丘斯 2 评分在库欣综合征患者主要不良心血管事件预测中的应用。
Int J Endocrinol. 2014;2014:138653. doi: 10.1155/2014/138653. Epub 2014 Jul 1.
2
The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.在接受抗凝治疗的房颤患者中,HAS-BLED 评分对大出血的预测准确性优于 CHADS2 或 CHA2DS2-VASc 评分。
J Am Coll Cardiol. 2013 Dec 10;62(23):2199-204. doi: 10.1016/j.jacc.2013.08.1623. Epub 2013 Sep 18.
3
The CHADS2 and CHA2DS2-VASc scores predict adverse vascular function, ischemic stroke and cardiovascular death in high-risk patients without atrial fibrillation: role of incorporating PR prolongation.CHADS2和CHA2DS2-VASc评分可预测无房颤的高危患者的不良血管功能、缺血性卒中和心血管死亡:纳入PR间期延长的作用。
Atherosclerosis. 2014 Dec;237(2):504-13. doi: 10.1016/j.atherosclerosis.2014.08.026. Epub 2014 Aug 30.
4
Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the RE-LY trial.在接受达比加群或华法林治疗的房颤患者中,与 CHADS2 评分相关的卒中和出血风险及死亡率:RE-LY 试验的亚组分析。
Ann Intern Med. 2011 Nov 15;155(10):660-7, W204. doi: 10.7326/0003-4819-155-10-201111150-00004.
5
CHADS2 scores as a predictor of ischemic stroke after radical prostatectomy.CHADS2评分作为根治性前列腺切除术后缺血性卒中的预测指标。
Cancer Med. 2016 Jan;5(1):3-8. doi: 10.1002/cam4.557. Epub 2015 Nov 21.
6
CHADS2, CHA2DS2-VASc, ATRIA, and Essen stroke risk scores in stroke with atrial fibrillation: A nationwide multicenter registry study.CHA2DS2-VASc、ATRIA、Essen 卒中风险评分与非瓣膜性心房颤动相关性卒中:一项全国多中心注册研究。
Medicine (Baltimore). 2021 Jan 22;100(3):e24000. doi: 10.1097/MD.0000000000024000.
7
CHADS2 Scores as a Predictor of Ischemic Stroke in Patients With Peripheral Artery Disease.CHADS2 评分预测外周动脉疾病患者的缺血性脑卒中。
Mayo Clin Proc. 2016 Jan;91(1):45-50. doi: 10.1016/j.mayocp.2015.09.021. Epub 2015 Dec 8.
8
The impact of risk score (CHADS2 versus CHA2DS2-VASc) on long-term outcomes after atrial fibrillation ablation.风险评分(CHADS2与CHA2DS2-VASc)对心房颤动消融术后长期预后的影响。
Heart Rhythm. 2015 Apr;12(4):681-6. doi: 10.1016/j.hrthm.2014.12.034. Epub 2014 Dec 26.
9
An evaluation of the CHADS₂ stroke risk score in patients with atrial fibrillation who undergo percutaneous coronary revascularization.经皮冠状动脉血运重建术治疗的心房颤动患者中 CHADS₂ 卒中风险评分的评估。
Chest. 2011 Jun;139(6):1402-1409. doi: 10.1378/chest.10-1408. Epub 2010 Sep 23.
10
CHA2DS2-VASc scores predict major adverse cardiovascular events in patients with chronic obstructive pulmonary disease.CHA2DS2-VASc评分可预测慢性阻塞性肺疾病患者的主要不良心血管事件。
Clin Respir J. 2018 Mar;12(3):1038-1045. doi: 10.1111/crj.12624. Epub 2017 Mar 29.

引用本文的文献

1
Endocrine Disorders and Peripheral Arterial Disease - A Series of Reviews Cushing Syndrome-Cortisol Excess.内分泌紊乱与外周动脉疾病 - 系列综述 库欣综合征 - 皮质醇过多症。
Curr Vasc Pharmacol. 2024;22(4):236-241. doi: 10.2174/0115701611272145231106053914.
2
Rheumatoid arthritis significantly increased recurrence risk after ischemic stroke/transient ischemic attack.类风湿关节炎显著增加缺血性卒中和短暂性脑缺血发作后的复发风险。
J Neurol. 2018 Aug;265(8):1810-1818. doi: 10.1007/s00415-018-8885-9. Epub 2018 Jun 2.
3
Association between hyperglycaemic crisis and long-term major adverse cardiovascular events: a nationwide population-based, propensity score-matched, cohort study.

本文引用的文献

1
Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study.无功能性肾上腺意外瘤或伴有中间型表型或亚临床库欣综合征患者的心血管事件和死亡率:一项 15 年回顾性研究。
Lancet Diabetes Endocrinol. 2014 May;2(5):396-405. doi: 10.1016/S2213-8587(13)70211-0. Epub 2014 Jan 29.
2
Clinical Characteristics of Endogenous Cushing's Syndrome at a Medical Center in Southern Taiwan.台湾南部某医学中心之内源性库欣氏症候群之临床特徵。
Int J Endocrinol. 2013;2013:685375. doi: 10.1155/2013/685375. Epub 2013 Aug 22.
3
高血糖危象与长期主要心血管不良事件之间的关联:一项基于全国人群的倾向评分匹配队列研究。
BMJ Open. 2016 Aug 23;6(8):e012233. doi: 10.1136/bmjopen-2016-012233.
4
Prediction of Mortality in Incident Hemodialysis Patients: A Validation and Comparison of CHADS2, CHA2DS2, and CCI Scores.新发病血液透析患者死亡率的预测:CHADS2、CHA2DS2和CCI评分的验证与比较
PLoS One. 2016 May 5;11(5):e0154627. doi: 10.1371/journal.pone.0154627. eCollection 2016.
5
CHADS2 scores as a predictor of ischemic stroke after radical prostatectomy.CHADS2评分作为根治性前列腺切除术后缺血性卒中的预测指标。
Cancer Med. 2016 Jan;5(1):3-8. doi: 10.1002/cam4.557. Epub 2015 Nov 21.
Cushing's disease in 2012.
2012年的库欣病。
Endocrinol Nutr. 2014 Feb;61(2):93-9. doi: 10.1016/j.endonu.2013.05.003. Epub 2013 Sep 14.
4
Mortality in Cushing's syndrome: systematic analysis of a large series with prolonged follow-up.库欣综合征患者的死亡率:一项具有长期随访的大型系列研究的系统分析。
Eur J Endocrinol. 2013 Oct 8;169(5):715-23. doi: 10.1530/EJE-13-0569. Print 2013 Nov.
5
Mortality in Cushing's syndrome: data from 386 patients from a single tertiary referral center.库欣综合征患者的死亡率:来自一家三级转诊中心的 386 例患者的数据。
Eur J Endocrinol. 2013 Oct 1;169(5):621-7. doi: 10.1530/EJE-13-0320. Print 2013 Nov.
6
Multisystem morbidity and mortality in Cushing's syndrome: a cohort study.库欣综合征的多系统发病率和死亡率:一项队列研究。
J Clin Endocrinol Metab. 2013 Jun;98(6):2277-84. doi: 10.1210/jc.2012-3582. Epub 2013 Mar 26.
7
Evaluation of the CHADS2 risk score on short- and long-term all-cause and cardiovascular mortality after syncope.晕厥后短期和长期全因和心血管死亡率的 CHADS2 风险评分评估。
Clin Cardiol. 2013 May;36(5):262-8. doi: 10.1002/clc.22102. Epub 2013 Feb 28.
8
Stroke after coronary artery bypass grafting: preoperative predictive accuracies of CHADS2 and CHA2DS2VASc stroke risk stratification schemes.冠状动脉旁路移植术后的脑卒中:CHADS2 和 CHA2DS2VASc 脑卒中风险分层方案的术前预测准确性。
J Thorac Cardiovasc Surg. 2012 Dec;144(6):1428-35. doi: 10.1016/j.jtcvs.2012.07.053. Epub 2012 Aug 24.
9
Cushing's disease.库欣病。
Orphanet J Rare Dis. 2012 Jun 18;7:41. doi: 10.1186/1750-1172-7-41.
10
Mortality in Cushing's syndrome: a systematic review and meta-analysis.库欣综合征患者的死亡率:一项系统评价和荟萃分析。
Eur J Intern Med. 2012 Apr;23(3):278-82. doi: 10.1016/j.ejim.2011.10.013. Epub 2011 Nov 15.